271 related articles for article (PubMed ID: 6202923)
1. Suppression of natural killer cell activity by Friend murine leukemia virus.
Moody DJ; Specter S; Bendinelli M; Friedman H
J Natl Cancer Inst; 1984 Jun; 72(6):1349-56. PubMed ID: 6202923
[TBL] [Abstract][Full Text] [Related]
2. Natural killer (NK) cells and interferon in Friend-virus-infected susceptible and resistant mice.
Hertenstein B; Kreja L; Seidel HJ
Exp Hematol; 1984 Aug; 12(7):603-9. PubMed ID: 6204881
[TBL] [Abstract][Full Text] [Related]
3. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
4. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
5. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
6. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
Afifi MS; Bennett M; Kumar V
Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of natural killer cell activity in MoLV leukemogenesis: evidence for tumor-cell-mediated suppression.
Ofir R; Weinstein Y; Rager-Zisman B
Nat Immun Cell Growth Regul; 1988; 7(2):77-86. PubMed ID: 2842667
[TBL] [Abstract][Full Text] [Related]
8. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
Hsu KH; Friedman H
J Natl Cancer Inst; 1985 Jul; 75(1):105-10. PubMed ID: 3859684
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of erythroid target cells for Friend murine leukemia virus by intravenous pyran treatment.
Schuller GB; Morahan PS
J Natl Cancer Inst; 1979 May; 62(5):1257-60. PubMed ID: 286101
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
Stein-Streilein J; Bennett M; Mann D; Kumar V
J Immunol; 1983 Dec; 131(6):2699-704. PubMed ID: 6644021
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of murine leukemia. XI. differential susceptibility of spleen cells from serum-protected mice to the in vitro immunosuppressive effects of Friend leukemia virus-infected splenocytes.
Pettey CL; Collins JJ
Int J Cancer; 1984 Aug; 34(2):269-76. PubMed ID: 6540757
[TBL] [Abstract][Full Text] [Related]
13. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice.
Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL
J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of murine leukemia. VIII. Efficacy of passive serum therapy of Friend leukemia virus-induced disease in immunocompromised mice.
Genovesi EV; Livnat D; Collins JJ
J Natl Cancer Inst; 1983 Feb; 70(2):311-22. PubMed ID: 6337292
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of human lactoferrin and recombinant murine interferon-gamma on disease progression in mice infected with the polycythemia-inducing strain of the Friend virus complex.
Lu L; Shen RN; Zhou SZ; Srivastava C; Harrington M; Miyazawa K; Wu B; Lin ZH; Ruscetti S; Broxmeyer HE
Int J Hematol; 1991 Apr; 54(2):117-24. PubMed ID: 1660735
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
Sanfilippo F; Genovesi EV; Collins JJ
J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor cells in spleens of mice with low natural killer activity.
Blair PB; Staskawicz MO; Sam JS
J Natl Cancer Inst; 1983 Sep; 71(3):571-7. PubMed ID: 6577231
[TBL] [Abstract][Full Text] [Related]
18. Amplification of natural killer activity of mouse lymphocytes by vincristine.
De Vecchis L; Pastore S; Migliorati G; Bonmassar Giuliani A; Frati L
Int J Tissue React; 1982; 4(4):283-9. PubMed ID: 6220991
[TBL] [Abstract][Full Text] [Related]
19. Cellular tropism and localization in the rodent nervous system of a neuropathogenic variant of Friend murine leukemia virus.
Hoffman PM; Cimino EF; Robbins DS; Broadwell RD; Powers JM; Ruscetti SK
Lab Invest; 1992 Sep; 67(3):314-21. PubMed ID: 1405490
[TBL] [Abstract][Full Text] [Related]
20. Anti-Friend virus antibody-induced resistance of Friend virus-infected spleen cells to lysis mediated by anti-H-2 antisera.
Bubbers JE; Lilly F
Cancer Res; 1978 Sep; 38(9):2722-8. PubMed ID: 679177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
